GLUE Monte Rosa Therapeutics, Inc.

Fundamentals / CIK 0001826457 / USD

Monte Rosa Therapeutics, Inc. reported $70.33M in revenue and a net loss of $130.9M for the trailing twelve months ended September 30, 2026 (up 325.8% year over year), with a -214.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GLUE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$136.2M$68.09M$0-$137.1MFY 2020 Net Income: -$35.88M2020FY 2021 Net Income: -$73.96M2021FY 2022 Net Income: -$108.5M2022FY 2023 Revenue: $0FY 2023 Net Income: -$135.4M2023FY 2024 Revenue: $75.62MFY 2024 Net Income: -$72.70M2024FY 2025 Revenue: $123.7MFY 2025 Net Income: -$38.60M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $123.7M $75.62M $0 -- -- --
Research & Development $141.5M $121.6M $111.3M $85.06M $57.16M $24.00M
Total Operating Expenses $177.9M $156.7M $143.3M $112.4M $72.88M $28.01M
Operating Income -$54.21M -$81.11M -$143.3M -$112.4M -$72.88M -$28.01M
EBITDA -$43.35M -$70.89M -$135.0M -$106.1M -$70.75M -$27.47M
Income Before Tax -$39.72M -$70.13M -$135.0M -$108.5M -- --
Income Tax Expense -$1.10M $2.57M $338K $0 -- --
Net Income -$38.60M -$72.70M -$135.4M -$108.5M -$73.96M -$35.88M
Basic EPS -- -- -- -- -$2.96 -$23.65
Diluted EPS -- -- -- -- -$2.96 -$23.65
Basic Shares Outstanding 83.1M 73.9M 51.4M 47.2M 25.0M 1.5M
Diluted Shares Outstanding 83.1M 73.9M 51.4M 47.2M 25.0M 1.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $54.37M $8.97M $4.21M $2.78M $12.77M $23.19M $84.93M $60.65M
Research & Development $45.36M $47.96M $44.07M $41.98M $36.68M $30.65M $32.19M $38.87M
Total Operating Expenses $56.30M $58.10M $54.24M $52.50M $45.74M $38.75M $40.89M $47.64M
Operating Income -$1.94M -$49.13M -$50.03M -$49.72M -$32.98M -$15.55M $44.04M $13.00M
EBITDA $920K -$46.51M -$47.36M -$46.95M -$30.24M -$12.81M $46.66M $15.58M
Income Before Tax $3.78M -$43.19M -$44.45M -$46.08M -$30.26M -$11.10M $47.71M $15.60M
Income Tax Expense $716K $208K $52K $59K -$3.18M $1.20M $822K $2.16M
Net Income $3.06M -$43.40M -$44.50M -$46.11M -$27.08M -$12.29M $46.88M $13.44M
Basic Shares Outstanding 101.8M 101.5M 99.9M -- 82.4M 82.2M 82.1M --
Diluted Shares Outstanding 108.6M 101.5M 99.9M -- 82.4M 82.2M 83.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $129.9M $224.3M $128.1M $54.91M $346.1M $41.70M
Cash & Short-Term Investments $377.1M $224.3M $128.1M $54.91M $346.1M $41.70M
Total Current Assets $393.2M $377.4M $236.2M $275.9M $348.7M $43.59M
Property, Plant & Equipment, Net $25.99M $29.48M $33.80M $27.07M $12.32M $4.62M
Other Non-Current Assets $148K $115K $352K $278K $0 --
Total Non-Current Assets $55.47M $61.29M $67.54M $66.50M $17.66M $5.79M
Total Assets $448.7M $438.7M $303.8M $342.4M $366.3M $49.38M
Accounts Payable $3.55M $17.21M $11.15M $7.86M $6.56M $7.07M
Deferred Revenue (Current) $29.57M $117.2M $17.68M $0 -- --
Other Current Liabilities -- $3.35M $1.67M $5.02M $840K $1.40M
Total Current Liabilities $64.21M $156.9M $46.59M $25.57M $16.64M $29.27M
Total Non-Current Liabilities $151.4M $58.85M $77.91M $45.41M $2.18M $1.07M
Total Liabilities $215.6M $215.8M $124.5M $70.98M $18.81M $30.34M
Total Debt (incl. Leases) $39.19M $42.72M $46.04M $47.00M -- --
Common Stock $7.0K $6.0K $5.0K $5.0K $5.0K $1.0K
Retained Earnings -$477.2M -$438.6M -$365.9M -$230.5M -$122.0M -$48.08M
Accumulated Other Comp. Income -$3.83M -$3.36M -$2.72M -$1.75M -$2.02M -$1.06M
Total Stockholders' Equity $233.1M $222.9M $179.2M $271.4M $347.5M -$48.73M
Total Equity $233.1M $222.9M $179.2M $271.4M $347.5M -$48.73M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $45.18M $90.10M $159.9M $129.9M $208.3M $69.43M $78.53M $224.3M
Cash & Short-Term Investments $577.7M $621.1M $666.2M $377.1M $391.3M $290.6M $78.53M $224.3M
Total Current Assets $640.1M $631.4M $677.5M $393.2M $401.8M $299.5M $332.3M $377.4M
Property, Plant & Equipment, Net $28.63M $29.93M $28.41M $25.99M $27.60M $29.05M $29.34M $29.48M
Other Non-Current Assets $767K $828K $832K $148K $411K $445K $440K $115K
Total Non-Current Assets $57.66M $59.76M $58.88M $55.47M $58.02M $60.12M $60.92M $61.29M
Total Assets $697.7M $691.2M $736.4M $448.7M $459.8M $359.6M $393.2M $438.7M
Accounts Payable $3.35M $7.15M $7.90M $3.55M $14.51M $5.58M $6.49M $17.21M
Deferred Revenue (Current) $21.10M $22.10M $33.06M $29.57M $24.79M $18.41M $32.58M $117.2M
Other Current Liabilities -- -- -- -- $1.65M $1.51M $4.42M $3.35M
Total Current Liabilities $62.05M $59.66M $71.04M $64.21M $61.44M $41.85M $59.22M $156.9M
Total Non-Current Liabilities $139.5M $144.2M $143.5M $151.4M $152.6M $49.65M $58.82M $58.85M
Total Liabilities $201.5M $203.9M $214.5M $215.6M $214.0M $91.51M $118.0M $215.8M
Total Debt (incl. Leases) $36.27M $37.99M $39.06M $39.19M $40.17M $41.13M $41.86M $42.72M
Common Stock $9.0K $9.0K $8.0K $7.0K $6.0K $6.0K $6.0K $6.0K
Retained Earnings -$562.1M -$565.1M -$521.7M -$477.2M -$431.1M -$404.0M -$391.7M -$438.6M
Accumulated Other Comp. Income -$6.19M -$5.17M -$4.75M -$3.83M -$3.25M -$3.37M -$3.33M -$3.36M
Total Stockholders' Equity $496.2M $487.3M $521.9M $233.1M $245.8M $268.1M $275.2M $222.9M
Total Equity $496.2M $487.3M $521.9M $233.1M $245.8M $268.1M $275.2M $222.9M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$38.63M -$72.70M -$135.4M -$108.5M -$73.96M -$35.88M
Depreciation & Amortization $10.86M $10.22M $8.32M $6.25M $2.13M $537K
Stock-Based Compensation $18.86M $18.13M $16.67M $11.66M $5.20M $354K
Change in Payables -$13.71M $6.25M $5.76M -$744K -$706K $3.44M
Operating Cash Flow -$22.80M $42.00M -$43.80M -$92.47M -$59.36M -$23.05M
Capital Expenditure -$4.70M -$3.99M -$19.04M -$12.91M -$9.73M -$3.39M
Free Cash Flow -$27.50M $38.01M -$62.84M -$105.4M -$69.09M -$26.44M
Purchases of Investments -$376.7M -$230.4M -$103.2M -$384.4M $0 --
Investing Cash Flow -$101.8M -$44.45M $88.80M -$219.2M -$9.65M -$3.39M
Common Stock Issued $345.0M -- $0 $20.05M $0 --
Dividends Paid $0 $0 $0 $0 $0 --
Financing Cash Flow $30.35M $98.89M $27.49M $20.47M $377.6M $60.06M
Net Change in Cash -$94.28M $96.44M $72.49M -$291.2M $308.5M $33.62M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $3.06M -$43.40M -$44.50M -$46.13M -$27.08M -$12.29M $46.88M $13.44M
Depreciation & Amortization $2.86M $2.62M $2.67M $2.76M $2.73M $2.74M $2.62M $2.57M
Stock-Based Compensation $6.32M $5.97M $5.95M $4.31M $4.36M $4.89M $5.30M $4.47M
Change in Payables -$3.40M -$1.49M $4.38M -$10.61M $8.88M -$1.10M -$10.87M $13.31M
Operating Cash Flow -$40.98M -$44.11M -$37.37M -$43.01M $100.4M -$34.72M -$45.49M $128.9M
Capital Expenditure -$1.56M -$4.72M -$1.87M -$767K -$651K -$1.70M -$1.59M -$183K
Free Cash Flow -$42.54M -$48.84M -$39.24M -$43.78M $99.78M -$36.41M -$47.08M $128.7M
Purchases of Investments -$91.71M -$76.07M -$332.0M -$153.7M -$65.97M -$19.03M -$138.0M -$67.96M
Investing Cash Flow -$4.54M -$28.86M -$261.0M -$65.07M $38.14M $25.32M -$100.2M -$30.90M
Dividends Paid $0 $0 $0 $0 $0 $0 $0 $0
Financing Cash Flow $568K $3.21M $328.3M $29.62M $348K $365K $14K $608K
Net Change in Cash -$44.95M -$69.76M $29.97M -$78.46M $138.9M -$9.03M -$145.7M $98.63M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -43.8% -107.3% -- -- -- --
Net Profit Margin -31.2% -96.1% -- -- -- --
Return on Equity (ROE) -16.6% -32.6% -75.5% -40.0% -21.3% --
Return on Assets (ROA) -8.6% -16.6% -44.6% -31.7% -20.2% -72.7%
Current Ratio 6.12x 2.40x 5.07x 10.79x 20.96x 1.49x
Quick Ratio 5.87x 1.43x 2.75x 2.15x 20.80x 1.42x
Debt to Equity 0.17x 0.19x 0.26x 0.17x -- --
Revenue Growth (YoY) +63.5% -- -- -- -- --
Operating Cash Flow Growth (YoY) -154.3% -- -- -- -- --
Free Cash Flow Growth (YoY) -172.3% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -214.5% -633.0% -345.2% -43.8% 4.7% 8.4% -1.3% -107.3%
Net Profit Margin -186.2% -560.8% -302.6% -31.2% 11.5% 13.6% 3.9% -96.1%
Return on Equity (ROE) -26.4% -33.1% -24.9% -16.6% 8.5% 9.0% 2.2% -32.6%
Return on Assets (ROA) -18.8% -23.3% -17.7% -8.6% 4.6% 6.7% 1.6% -16.6%
Current Ratio 10.32x 10.58x 9.54x 6.12x 6.54x 7.16x 5.61x 2.40x
Quick Ratio 9.31x 10.41x 9.38x 5.87x 6.37x 6.94x 1.33x 1.43x
Debt to Equity 0.07x 0.08x 0.07x 0.17x 0.16x 0.15x 0.15x 0.19x
Revenue Growth (YoY) +325.8% -61.3% -95.0% -95.4% +38.5% +394.0% +7882.0% --
Operating Income Growth (YoY) -- -- -213.6% -482.3% -- -- -- --
Net Income Growth (YoY) -- -- -194.9% -443.1% -- -- -- --
Operating Cash Flow Growth (YoY) -140.8% -- -- -133.4% -- -- -- +335.0%
Free Cash Flow Growth (YoY) -142.6% -- -- -134.0% -- -- -- +360.7%
Source: SEC EDGAR CompanyFacts (CIK 0001826457) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:31 UTC · Open in terminal